Strategic Sourcing & Procurement

Shubhangi Dua

AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

Nicole Dale

Can Large Language Models Solve More Rare Disease Genomes?

Pharmatica image showing a clinical geneticist using LLM-assisted rare disease diagnosis tools to analyse genome sequencing data and generate evidence-based diagnostic hypotheses for precision medicine.

LLM-assisted rare disease re-assessment improves genomic analysis, increasing diagnostic yield and supporting clinician-led precision medicine and possibly drug development.

Nicole Dale

AI Bioweapons Risk: What Anthropic’s Report Means for Pharma

Pharmatica image representing a pharmaceutical AI research environment that uses AI biosecurity, biological research governance, and emerging bioweapons risk.

The Anthropic 2026 threat report documents a significant bioweapons risk. See what this means for pharma biosecurity, research, and AI controls.

Nicole Dale

AI Creates New Viruses? Not Quite. AI-Designed Bacteriophages

Pharmatica image of AI-designed bacteriophage research in a biotech laboratory showing genome analysis, AI genome design, and phage development.

AI-designed bacteriophages show how genome models could create new antibacterial therapies while forcing pharma to rethink biological AI governance and biosecurity.

Nicole Dale

Ketryx and Accenture Build Regulated AI MedTech at Scale

Pharmatica image of regulated AI connecting medical device software development, validation, traceability, and regulatory compliance.

Ketryx and Accenture are combining AI-native compliance infrastructure and transformation expertise to help MedTech scale regulated AI without slowing development.

Nicole Dale

AI Breast Cancer Screening Moves From Trials to Policy

Pharmatica image of a bright radiology suite lit by natural light, with a soft blue imaging display and a glowing yellow highlight representing AI innovation in breast cancer screening.

AI breast cancer screening finds more cancers and cuts radiologist workload, but recall risks remain. See what MASAI, AITIC, and EDITH mean for MedTech teams.